Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation - Fig 3
- Julia M. Grottenthaler (5345897)
- Christoph R. Werner (483015)
- Martina Steurer (5345891)
- Ulrich Spengler (205545)
- Thomas Berg (186372)
- Cornelius Engelmann (3857854)
- Heiner Wedemeyer (32361)
- Thomas von Hahn (345025)
- Wolfgang Stremmel (46931)
- Anita Pathil (3097575)
- Ulrich Seybold (5345894)
- Eckart Schott (320945)
- Usha Blessin (5345888)
- Christoph Sarrazin (48298)
- Martin-Walter Welker (333015)
- Ellen Harrer (5345885)
- Stefan Scholten (210941)
- Clemens Hinterleitner (5345900)
- Ulrich M. Lauer (214418)
- Nisar P. Malek (127224)
- Christoph P. Berg (483018)
Publication date
June 2018
DOIAbstract
<p><b>(A) Changes of MELD scores in patients on the liver transplant waiting list.</b> Changes did not reach significance levels; ns = not significant, EOT = end of treatment, EO FU = end of follow-up. <b>(B) Changes of individual MELD scores in patients on the liver transplant waiting list</b>. Pt. 1–12: individual patients. EOT = end of treatment, EO FU = end of follow-up.</p
Add to ORKG